Siena Biotech S.p.A. Company Profile

22:24 EST 13th December 2018 | BioPortfolio

SIENABIOTECH is an innovative drug discovery company whose research efforts are focussed on diseases of the central nervous system, either neurodegenerative or proliferative, including rare diseases with the aim of discovering new therapeutic intervention.
In order to support the drug discovery process from exploratory target identification to clinical studies, the Company applies the most advanced technologies in the biomedical and biotechnology fields ranging from target identification and validation molecule identification, optimization and validation in clinical studies.




Phone: 39 0577 381111
Fax: 39 0577 381202

News Articles [1605 Associated News Articles listed on BioPortfolio]

Exosomics Siena Launches Exosome-Based Liquid Biopsy Technologies

NewsExosomics Siena S.p.A., a Lonza-backed diagnostics company, has launched its first proprietary liquid biopsy technologies for the selective isolation of tumor-derived nucleic acids from complex bi...

Exosomics Siena SpA Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryExosomics Siena SpA Exosomics Siena is a biotechnology company that offers research and development services. The company provides services such as contract research, collaborative project mana...

#jobs #lifescience Biotech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biotech .DE-Newark, Biotech Category: Scientific Type: Temp to Perm Descripti...

Biotech Report: BB Biotech und Vita34 fest, Sarepta und Puma Biotech leichter

( Frankfurt / New York 27.06.18 - Biotech-Aktien zeigten sich im deutschen Handel uneinheitlich. Mit BB Biotech und Vita34 gab es einige Gewinner. An der Wall Street sind die Kursgewi...

BB Biotech ist erste Wahl

Die Aktie von BB Biotech (WKN: A0NFN3 / ISIN: CH0038389992) ist eine tolle Alternative zu speziellen Fonds im Biotech-Sektor. Als Beteiligungsgesellschaft verfügt BB Biotech dabei über die Vorteile....

Biotech Report: 4SC und BB Biotech fester

( Frankfurt / New York 13.06.18 - Biotech-Werte zeigten sich im deutschen Handel durchwachsen. Mit 4SC und BB Biotech gab es durchaus Gewinner, auf der anderen Seite standen unter and...

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years ...

#jobs #lifescience BioPharm/BioTech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

Improving the SIENA performance using BEaST brain extraction.

We present an improved image analysis pipeline to detect the percent brain volume change (PBVC) using SIENA (Structural Image Evaluation, using Normalization, of Atrophy) in populations with Alzheimer...

Severe atherosclerosis in the natural mummy of Girolamo Macchi (1648-1734), "major writer" of Santa Maria della Scala Hospital in Siena (Italy).

A small crypt in the Santissima Annunziata Church of Santa Maria della Scala Hospital in Siena (Italy) contained three well-preserved mummies, two of which, dated back to the 15th-16th century, were i...

Third-quarter biotech job picture.

Second-quarter biotech job picture.

Public biotech in 2017-the numbers.

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Evaluation of the Hem-Avert® Perianal Stabilizer Into Routine Clinical Practice

This is a retrospective data-only study following the phased introduction of the HEM-AVERT® Perianal Stabilizer into routine clinical practice. The investigators aim to capitalize on the ...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Companies [928 Associated Companies listed on BioPortfolio]

Siena Biotech S.p.A.

SIENABIOTECH is an innovative drug discovery company whose research efforts are focussed on diseases of the central nervous system, either neurodegenerative or proliferative, including rare diseases w...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

More Information about "Siena Biotech S.p.A." on BioPortfolio

We have published hundreds of Siena Biotech S.p.A. news stories on BioPortfolio along with dozens of Siena Biotech S.p.A. Clinical Trials and PubMed Articles about Siena Biotech S.p.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Siena Biotech S.p.A. Companies in our database. You can also find out about relevant Siena Biotech S.p.A. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record